Osimertinib vs Ublituximab

## Osimertinib vs Ublituximab: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Ublituximab**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Ublituximab — N/A.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Ublituximab — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Ublituximab — N/A.

**Type**: Osimertinib — Small molecule; Ublituximab — Antibody.